These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34269068)

  • 1. Trends in liposomal nanocarrier strategies for the oral delivery of biologics.
    Mühlberg E; Burtscher M; Umstätter F; Fricker G; Mier W; Uhl P
    Nanomedicine (Lond); 2021 Aug; 16(20):1813-1832. PubMed ID: 34269068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for oral delivery of biologics: small carriers for big payloads.
    Cao Y; Rewatkar P; Wang R; Hasnain SZ; Popat A; Kumeria T
    Trends Pharmacol Sci; 2021 Nov; 42(11):957-972. PubMed ID: 34593258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligation strategies for targeting liposomal nanocarriers.
    Marqués-Gallego P; de Kroon AI
    Biomed Res Int; 2014; 2014():129458. PubMed ID: 25126543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Liposomes for Enhancement of Oral Drug Absorption.
    Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
    Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
    Jain S; Patil SR; Swarnakar NK; Agrawal AK
    Mol Pharm; 2012 Sep; 9(9):2626-35. PubMed ID: 22871060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of vancomycin by tetraether lipid liposomes.
    Uhl P; Pantze S; Storck P; Parmentier J; Witzigmann D; Hofhaus G; Huwyler J; Mier W; Fricker G
    Eur J Pharm Sci; 2017 Oct; 108():111-118. PubMed ID: 28716758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in liposome surface modification for oral drug delivery.
    Nguyen TX; Huang L; Gauthier M; Yang G; Wang Q
    Nanomedicine (Lond); 2016 May; 11(9):1169-85. PubMed ID: 27074098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive delivery strategies for biologics.
    Anselmo AC; Gokarn Y; Mitragotri S
    Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
    Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
    AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of archaeosomes as carriers for oral delivery of peptides.
    Li Z; Chen J; Sun W; Xu Y
    Biochem Biophys Res Commun; 2010 Apr; 394(2):412-7. PubMed ID: 20226174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches.
    Lee MK
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32183185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends.
    Sohail MF; Rehman M; Sarwar HS; Naveed S; Salman O; Bukhari NI; Hussain I; Webster TJ; Shahnaz G
    Int J Nanomedicine; 2018; 13():3145-3161. PubMed ID: 29922053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.
    Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY
    Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of oral drug delivery via nanocarriers.
    Reinholz J; Landfester K; Mailänder V
    Drug Deliv; 2018 Nov; 25(1):1694-1705. PubMed ID: 30394120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.
    Aburahma MH
    Drug Deliv; 2016 Jul; 23(6):1847-67. PubMed ID: 25390191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral inhalation for delivery of proteins and peptides to the lungs.
    Fröhlich E; Salar-Behzadi S
    Eur J Pharm Biopharm; 2021 Jun; 163():198-211. PubMed ID: 33852968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.